Sep 14, 2026
- Corporate
Personnel Changes
TOKYO, September 14, 2026 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced the following personnel changes, effective October 1, 2026.
[Details of Personnel Changes]
Department Heads
| Name | New Responsibilities | Current Responsibilities |
|---|---|---|
| Maki Yoshida |
Head of Analytical Development Dept., Pharmaceutical Technology Division |
Deputy Head of Analytical Development Dept. (Bio Product Analysis), Pharmaceutical Technology Division |
| Yoko Sano |
Head of Specialty Lifecycle Management Dept., Project Lifecycle Management Unit |
Head of Neuroscience Disease Area Strategy Group, Specialty Lifecycle Management Dept., Project Lifecycle Management Unit |
Contact:
- For Media
- Chugai Pharmaceutical Co., Ltd.
- Media Relations Group, Corporate Communications Dept.,
- Naoki Kouzai
- Tel: +81-3-3273-0881
- E-mail: pr@chugai-pharm.co.jp
- For Investors
- Chugai Pharmaceutical Co., Ltd.
- Investor Relations Group, Corporate Communications Dept.,
- Takayuki Sakurai
- Tel: +81-3-3273-0554
- E-mail: ir@chugai-pharm.co.jp